Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;39(2):259-260.
doi: 10.1111/jdv.20493.

Immunosuppression and Mohs surgery: Navigating risks in high-stakes skin cancer management

Warren M Perry  1 , Ally-Khan Somani  2   3
Affiliations

Immunosuppression and Mohs surgery: Navigating risks in high-stakes skin cancer management

Warren M Perry et al. J Eur Acad Dermatol Venereol. 2025 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

FIGURE 1
FIGURE 1
The characteristics of cutaneous squamous cell carcinoma (cSCC) and the subsequent poor outcomes in immunosuppressed patients, including solid organ transplant recipients (SOTR), bone marrow transplants, hematologic malignancy (chronic lymphocytic leukaemia—CLL), human immunodeficiency virus (HIV)/autoimmune deficiency syndrome (AIDS) and autoimmune conditions.
See this image and copyright information in PMC

References

    1. Abril‐Pérez C, Mansilla‐Polo M, Escutia‐Muñoz B, Sanmartín O, Garcés JR, Rodríguez‐Prieto MA, et al. Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: results of a prospective nationwide cohort study. J Eur Acad Dermatol Venereol. 2025;39:426–434. 10.1111/jdv.20103 - DOI - PubMed
    1. Thompson AK, Kelley BF, Prokop LJ, Murad MH, Baum CL. Risk factors for cutaneous squamous cell carcinoma outcomes: a systematic review and meta‐analysis. JAMA Dermatol. 2016;152(4):419–428. - PMC - PubMed
    1. Manyam BV, Garsa AA, Chin R‐I, Reddy CA, Gastman B, Thorstad W, et al. A multi‐institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck. Cancer. 2017;123(11):2054–2060. - PubMed
    1. Jambusaria‐Pahlajani A, Kanetsky PA, Karia PS, Hwang WT, Gelfand JM, Whalen FM, et al. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol. 2013;149:402–410. - PubMed
    1. Wysong A, Newman JG, Covington KR, Kurley SJ, Ibrahim SF, Farberg AS, et al. Validation of a 40‐gene expression profile test to predict metastatic risk in localized high‐risk cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2021;84(2):361–369. - PubMed

LinkOut - more resources